Global Neurological Drugs Market Research Report 2025
- Published Date: 2024-12-16
- Report ID: 9163831
- Pages: 200
-
Format:
Report Overview
Nervous system diseases are diseases that occur in the central nervous system, peripheral nervous system, and autonomic nervous system, mainly manifested in sensory, motor, consciousness, and autonomic dysfunction.
This report provides a deep insight into the global Neurological Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neurological Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neurological Drugs market in any manner.
Global Neurological Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Ely Lilly
Actavis
Mylan
Randox
Intellipharmaceutics
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
North China Pharmaceutical
Harbin Pharmaceutical Co., Ltd.
Lukang Pharmaceutical
Kelun Pharmaceutical
Kehua Biology
Market Segmentation (by Type)
Non-prescription drugs
Prescription
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Neurological Drugs Market
Overview of the regional outlook of the Neurological Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neurological Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurological Drugs
1.2 Key Market Segments
1.2.1 Neurological Drugs Segment by Type
1.2.2 Neurological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurological Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Neurological Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurological Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurological Drugs Market Competitive Landscape
3.1 Global Neurological Drugs Sales by Manufacturers (2019-2024)
3.2 Global Neurological Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurological Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurological Drugs Sales Sites, Area Served, Product Type
3.6 Neurological Drugs Market Competitive Situation and Trends
3.6.1 Neurological Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurological Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurological Drugs Industry Chain Analysis
4.1 Neurological Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurological Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurological Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurological Drugs Sales Market Share by Type (2019-2024)
6.3 Global Neurological Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Neurological Drugs Price by Type (2019-2024)
7 Neurological Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurological Drugs Market Sales by Application (2019-2024)
7.3 Global Neurological Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Neurological Drugs Sales Growth Rate by Application (2019-2024)
8 Neurological Drugs Market Segmentation by Region
8.1 Global Neurological Drugs Sales by Region
8.1.1 Global Neurological Drugs Sales by Region
8.1.2 Global Neurological Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Neurological Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurological Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurological Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurological Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurological Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Neurological Drugs Basic Information
9.1.2 Pfizer Neurological Drugs Product Overview
9.1.3 Pfizer Neurological Drugs Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Neurological Drugs SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Ely Lilly
9.2.1 Ely Lilly Neurological Drugs Basic Information
9.2.2 Ely Lilly Neurological Drugs Product Overview
9.2.3 Ely Lilly Neurological Drugs Product Market Performance
9.2.4 Ely Lilly Business Overview
9.2.5 Ely Lilly Neurological Drugs SWOT Analysis
9.2.6 Ely Lilly Recent Developments
9.3 Actavis
9.3.1 Actavis Neurological Drugs Basic Information
9.3.2 Actavis Neurological Drugs Product Overview
9.3.3 Actavis Neurological Drugs Product Market Performance
9.3.4 Actavis Neurological Drugs SWOT Analysis
9.3.5 Actavis Business Overview
9.3.6 Actavis Recent Developments
9.4 Mylan
9.4.1 Mylan Neurological Drugs Basic Information
9.4.2 Mylan Neurological Drugs Product Overview
9.4.3 Mylan Neurological Drugs Product Market Performance
9.4.4 Mylan Business Overview
9.4.5 Mylan Recent Developments
9.5 Randox
9.5.1 Randox Neurological Drugs Basic Information
9.5.2 Randox Neurological Drugs Product Overview
9.5.3 Randox Neurological Drugs Product Market Performance
9.5.4 Randox Business Overview
9.5.5 Randox Recent Developments
9.6 Intellipharmaceutics
9.6.1 Intellipharmaceutics Neurological Drugs Basic Information
9.6.2 Intellipharmaceutics Neurological Drugs Product Overview
9.6.3 Intellipharmaceutics Neurological Drugs Product Market Performance
9.6.4 Intellipharmaceutics Business Overview
9.6.5 Intellipharmaceutics Recent Developments
9.7 Astrazeneca
9.7.1 Astrazeneca Neurological Drugs Basic Information
9.7.2 Astrazeneca Neurological Drugs Product Overview
9.7.3 Astrazeneca Neurological Drugs Product Market Performance
9.7.4 Astrazeneca Business Overview
9.7.5 Astrazeneca Recent Developments
9.8 Lundbeck
9.8.1 Lundbeck Neurological Drugs Basic Information
9.8.2 Lundbeck Neurological Drugs Product Overview
9.8.3 Lundbeck Neurological Drugs Product Market Performance
9.8.4 Lundbeck Business Overview
9.8.5 Lundbeck Recent Developments
9.9 Allergan
9.9.1 Allergan Neurological Drugs Basic Information
9.9.2 Allergan Neurological Drugs Product Overview
9.9.3 Allergan Neurological Drugs Product Market Performance
9.9.4 Allergan Business Overview
9.9.5 Allergan Recent Developments
9.10 GSK
9.10.1 GSK Neurological Drugs Basic Information
9.10.2 GSK Neurological Drugs Product Overview
9.10.3 GSK Neurological Drugs Product Market Performance
9.10.4 GSK Business Overview
9.10.5 GSK Recent Developments
9.11 Otsuka Pharmaceutical
9.11.1 Otsuka Pharmaceutical Neurological Drugs Basic Information
9.11.2 Otsuka Pharmaceutical Neurological Drugs Product Overview
9.11.3 Otsuka Pharmaceutical Neurological Drugs Product Market Performance
9.11.4 Otsuka Pharmaceutical Business Overview
9.11.5 Otsuka Pharmaceutical Recent Developments
9.12 Takeda
9.12.1 Takeda Neurological Drugs Basic Information
9.12.2 Takeda Neurological Drugs Product Overview
9.12.3 Takeda Neurological Drugs Product Market Performance
9.12.4 Takeda Business Overview
9.12.5 Takeda Recent Developments
9.13 NHU Group
9.13.1 NHU Group Neurological Drugs Basic Information
9.13.2 NHU Group Neurological Drugs Product Overview
9.13.3 NHU Group Neurological Drugs Product Market Performance
9.13.4 NHU Group Business Overview
9.13.5 NHU Group Recent Developments
9.14 Shionogi
9.14.1 Shionogi Neurological Drugs Basic Information
9.14.2 Shionogi Neurological Drugs Product Overview
9.14.3 Shionogi Neurological Drugs Product Market Performance
9.14.4 Shionogi Business Overview
9.14.5 Shionogi Recent Developments
9.15 APOTEX
9.15.1 APOTEX Neurological Drugs Basic Information
9.15.2 APOTEX Neurological Drugs Product Overview
9.15.3 APOTEX Neurological Drugs Product Market Performance
9.15.4 APOTEX Business Overview
9.15.5 APOTEX Recent Developments
9.16 North China Pharmaceutical
9.16.1 North China Pharmaceutical Neurological Drugs Basic Information
9.16.2 North China Pharmaceutical Neurological Drugs Product Overview
9.16.3 North China Pharmaceutical Neurological Drugs Product Market Performance
9.16.4 North China Pharmaceutical Business Overview
9.16.5 North China Pharmaceutical Recent Developments
9.17 Harbin Pharmaceutical Co., Ltd.
9.17.1 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Basic Information
9.17.2 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Overview
9.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product Market Performance
9.17.4 Harbin Pharmaceutical Co., Ltd. Business Overview
9.17.5 Harbin Pharmaceutical Co., Ltd. Recent Developments
9.18 Lukang Pharmaceutical
9.18.1 Lukang Pharmaceutical Neurological Drugs Basic Information
9.18.2 Lukang Pharmaceutical Neurological Drugs Product Overview
9.18.3 Lukang Pharmaceutical Neurological Drugs Product Market Performance
9.18.4 Lukang Pharmaceutical Business Overview
9.18.5 Lukang Pharmaceutical Recent Developments
9.19 Kelun Pharmaceutical
9.19.1 Kelun Pharmaceutical Neurological Drugs Basic Information
9.19.2 Kelun Pharmaceutical Neurological Drugs Product Overview
9.19.3 Kelun Pharmaceutical Neurological Drugs Product Market Performance
9.19.4 Kelun Pharmaceutical Business Overview
9.19.5 Kelun Pharmaceutical Recent Developments
9.20 Kehua Biology
9.20.1 Kehua Biology Neurological Drugs Basic Information
9.20.2 Kehua Biology Neurological Drugs Product Overview
9.20.3 Kehua Biology Neurological Drugs Product Market Performance
9.20.4 Kehua Biology Business Overview
9.20.5 Kehua Biology Recent Developments
10 Neurological Drugs Market Forecast by Region
10.1 Global Neurological Drugs Market Size Forecast
10.2 Global Neurological Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurological Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Neurological Drugs Market Size Forecast by Region
10.2.4 South America Neurological Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurological Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neurological Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurological Drugs by Type (2025-2030)
11.1.2 Global Neurological Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurological Drugs by Type (2025-2030)
11.2 Global Neurological Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Neurological Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Neurological Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
